The increased expression of FZD8 in a significant proportion of prostate tumors and the demonstrated inhibitory effect of FZD8 silencing on prostate cancer cell migration and invasion suggests that inhibition of WNT-FZD8 interactions may be a useful approach for treatment of patients with metastatic prostate cancer. Here, FZD8 is linked to prostate neoplasm.